TP53 and leukemia: Hsu et al. [14] reported that treating mouse leukemia WEHI-3 cells with gypenosides (150 μg/mL) upregulated p53, increased reactive oxygen species (ROS) and Ca2+ production, and decreased ∆Ψm levels.